Published in Am J Hypertens on July 01, 1992
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. Ann Oncol (2009) 5.08
Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. JAMA (1996) 2.67
Use of antiasthmatic drugs in Australia. Med J Aust (1990) 2.47
Smoking as a risk factor for cerebral ischaemia. Lancet (1989) 2.26
Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ (1994) 2.25
Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N Engl J Med (1997) 2.21
Are asthma medications and management related to deaths from asthma? Am J Respir Crit Care Med (2001) 2.19
Why older patients of lower clinical urgency choose to attend the emergency department. Intern Med J (2013) 2.19
The effects of bonus payments on emergency service performance in Victoria. Med J Aust (1999) 2.16
PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension in Australia, 1994-1998. Med J Aust (2001) 2.15
Hormone replacement therapy in postmenopausal women protects against smoking-induced changes in vascular structure and function. J Am Coll Cardiol (1999) 2.09
Trials of streptokinase in severe acute ischaemic stroke. Lancet (1995) 1.98
Risk factors for lacunar infarction syndromes. Neurology (1995) 1.97
Dalteparin for deep venous thrombosis: a hospital-in-the-home program. Med J Aust (1998) 1.90
Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet (1989) 1.84
Use of radial artery applanation tonometry and a generalized transfer function to determine aortic pressure augmentation in subjects with treated hypertension. J Am Coll Cardiol (1998) 1.73
Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. BMJ (1995) 1.70
Incidence of the major stroke subtypes: initial findings from the North East Melbourne stroke incidence study (NEMESIS). Stroke (2001) 1.69
Maxillofacial trauma in major trauma patients. Aust Dent J (2006) 1.68
Pharmacokinetics of the H2- receptor antagonist ranitidine in man. Br J Clin Pharmacol (1981) 1.67
Linking prescription and patient-identifying data: a pilot study. Med J Aust (1992) 1.48
Stroke incidence on the east coast of Australia: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke (2000) 1.48
The PACE pilot study: 12-month results and implications for future primary prevention trials in the elderly. (Prevention with low-dose Aspirin of Cardiovascular disease in the Elderly) J Am Geriatr Soc (1994) 1.45
Eosinophilia-myalgia syndrome: lessons for public health researchers. Med J Aust (1993) 1.44
Tampons: a novel patient-administered method for the assessment of genital human papillomavirus infection. J Infect Dis (1992) 1.44
Non-invasive measurements of arterial structure and function: repeatability, interrelationships and trial sample size. Clin Sci (Lond) (1998) 1.43
Out-of-hospital cardiac arrest. Med J Aust (2000) 1.42
Asystolic cardiac arrest in Melbourne, Australia. Emerg Med (Fremantle) (2001) 1.41
Should smoking be an indication for lipid-lowering therapy? Med J Aust (1999) 1.40
Cardiac risk factor management. Experience of an outpatient hypertension clinic. Med J Aust (1991) 1.40
Australians with renal disease: a new national survey. Med J Aust (1999) 1.38
Trends in prescribing of antihypertensive drugs in Australia, 1977-1987. Med J Aust (1990) 1.38
Hypertension and stroke. J Hypertens (1994) 1.38
Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke (2001) 1.36
Ischemic stroke risk and passive exposure to spouses' cigarette smoking. Melbourne Stroke Risk Factor Study (MERFS) Group. Am J Public Health (1999) 1.34
Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension. Lancet (1979) 1.34
Informal care for stroke survivors: results from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke (2002) 1.31
The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol Dial Transplant (2001) 1.30
Community-based recruitment strategies for a longitudinal interventional study: the VECAT experience. J Clin Epidemiol (2000) 1.30
Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer (1997) 1.26
Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab (2001) 1.24
A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension. Br J Clin Pharmacol (1979) 1.23
Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin Endocrinol Metab (2005) 1.21
Interrater reliability of the National Institutes of Health Stroke Scale: rating by neurologists and nurses in a community-based stroke incidence study. Cerebrovasc Dis (1999) 1.21
The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric (2000) 1.18
Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis (2005) 1.17
Progress and evaluation of a consultation-liaison psychiatry service to an obstetric-gynaecology hospital. Aust N Z J Psychiatry (1996) 1.16
An evaluation of laparoscopic versus open cholecystectomy. Med J Aust (1994) 1.16
Monitoring chemical exposure using breast milk: a methodological review. Am J Epidemiol (1992) 1.15
A randomized controlled clinical trial of pharmacokinetic theophylline dosing. Am Rev Respir Dis (1986) 1.13
Adverse effects of low-dose aspirin in a healthy elderly population. Clin Pharmacol Ther (1993) 1.12
Erythroid toxicity of azathioprin. Macrocytosis and selective marrow hypoplasis. Q J Med (1975) 1.11
Vascular dysfunction and autonomic neuropathy in Type 2 diabetes. Diabet Med (2004) 1.10
Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects. Br J Clin Pharmacol (1979) 1.10
Traumatic pneumobilia: case report. J Trauma (2001) 1.10
Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis (1992) 1.09
Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Melbourne Risk Factor Study (MERFS) Group. Stroke (1996) 1.08
Risk factors for stroke due to cerebral infarction in young adults. Stroke (1997) 1.08
Tumours of the brain and presence of antibodies to Toxoplasma gondii. Int J Epidemiol (1993) 1.07
Trends in Australian mortality of asthma, 1979-1985. Med J Aust (1989) 1.06
Ovarian sensitization to gonadotrophins by human growth hormone. Persistence of the effect beyond the treated cycle. Clin Endocrinol (Oxf) (1991) 1.05
Risk factors for cardiovascular disease in chronic spinal cord injury patients. Paraplegia (1992) 1.04
Risk factors for development of flucloxacillin associated jaundice. BMJ (1993) 1.04
Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Melbourne Risk Factor Study Group. Hypertension (1998) 1.04
Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practice. J Rheumatol (1992) 1.04
Drug doping in senior Australian rules football: a survey for frequency. Br J Sports Med (1997) 1.03
Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Australia. Int J Cancer (1994) 1.03
How safe are beta-blocking drugs? Med J Aust (1977) 1.01
Antismoking products. Med J Aust (1991) 1.01
Epidemiology of intracerebral hemorrhage. Epidemiol Rev (1995) 1.01
Plasma catecholamines and the pressor response to Sar1-Ala8-angiotensin II in man. Clin Sci Mol Med (1977) 1.01
Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients. Clin Sci (Lond) (1981) 1.00
Methods for detecting age-related maculopathy: a comparison between photographic and clinical assessment. Clin Experiment Ophthalmol (2000) 1.00
Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension. Clin Exp Pharmacol Physiol Suppl (1982) 0.99
Impact of a pharmacokinetics consultation service on clinical outcomes in an ambulatory-care epilepsy clinic. Am J Hosp Pharm (1988) 0.99
Results from the first 12 months of a fire first-responder program in Australia. Resuscitation (2001) 0.97
Catecholamines in peripheral venous plasma in patients on chronic haemodialysis. Clin Sci Mol Med (1978) 0.93
Improving patient-doctor concordance: an intervention study in general practice. Fam Pract (1996) 0.93
Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. Arterioscler Thromb Vasc Biol (2000) 0.93
Serum inhibin during lactation: relation to the gonadotrophins and gonadal steroids. Clin Endocrinol (Oxf) (1994) 0.93
Effect of age on pharmacokinetics of and blood pressure responses to prazosin and terazosin. J Cardiovasc Pharmacol (1987) 0.92
Treatment of hypertension with angiotensin converting enzyme inhibitors. Clin Exp Pharmacol Physiol Suppl (1982) 0.92
Comparison of recruitment strategies for a large-scale clinical trial in the elderly. J Clin Epidemiol (1991) 0.92
Angiotensin converting enzyme inhibition in renovascular hypertension: frequency of reversible renal failure. Lancet (1984) 0.92
Use of captopril in the diagnosis of renal hypertension. Aust N Z J Med (1981) 0.91
Clinical utility of distributed source modelling of interictal scalp EEG in focal epilepsy. Clin Neurophysiol (2010) 0.91
The Victorian Lung Cancer Registry pilot: improving the quality of lung cancer care through the use of a disease quality registry. Lung (2014) 0.91
Vascular dysfunction and metabolic parameters in polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.90
Tobacco smoking and alcohol consumption as risk factors for glioma: a case-control study in Melbourne, Australia. J Epidemiol Community Health (1996) 0.90
Pregnancies complicated by abnormally adherent placenta and sex ratio at birth. BMJ (1991) 0.90
Cost-effectiveness of prescribing statins according to pharmaceutical benefits scheme criteria. Med J Aust (2001) 0.90
The risk of ano-genital malignancies in dialysis and transplant patients. Clin Nephrol (1994) 0.90
Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients. Clin Exp Pharmacol Physiol (1981) 0.90
Herbal preparations--to regulate or not to regulate? Med J Aust (1989) 0.90
Pharmacokinetic and gastric secretory studies of ranitidine in man. Scand J Gastroenterol Suppl (1981) 0.89
Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study. BMJ (1999) 0.89
Enalapril reduces the catecholamine response to exercise in patients with heart failure. Eur J Clin Pharmacol (1986) 0.89
Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia. Clin Exp Hypertens (1997) 0.89